Zimmer Biomet Continues Technology Evolution in First Quarter

Zimmer Biomet

Zimmer Biomet reported 1Q21 orthopedic revenue of USD $1,665 million, +3.3% vs. 1Q20. Like many of its competitors, the company saw better than expected results in March to offset early-quarter COVID pressure. Compared to 1Q19, Zimmer Biomet’s orthopedic business declined in the high single digits. However, company leadership believes that...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us